Aristocrat Leisure shares test buyback value after A$60 break

Aristocrat Leisure shares test buyback value after A$60 break

June 29, 2026

Sydney, June 30, 2026, 04:02 AEST

  • Aristocrat Leisure Limited closed Monday at A$60.51, up 3.10%, while the S&P/ASX 200 (INDEXASX:XJO) rose 0.68% to 8,823.4.
  • Aristocrat’s June 29 buyback filing shows A$1.391 billion spent through June 26, leaving about A$1.109 billion under the A$2.5 billion program.
  • At Monday’s close, the remaining buyback would retire about 18.3 million shares, roughly 1.4 million fewer than at the average price paid so far.
  • The report is pre-open in Sydney; ASX normal cash trading starts from 09:59:45 Sydney time and runs to 16:00.

Aristocrat Leisure Limited goes into Tuesday with a buyback that is still large, but now less cheap. The stock closed Monday at A$60.51, up 3.10%, after trading between A$59.40 and A$60.62 on volume of 1.63 million shares. The S&P/ASX 200 (INDEXASX:XJO) gained 0.68% on the same day.

The latest filing says Aristocrat bought 193,344 shares on June 26 for A$11.34 million. It had bought 24.56 million shares before that for A$1.379 billion. The on-market program was raised to up to A$2.5 billion in May and runs to May 12, 2027.

That puts total stock bought through June 26 at 24.76 million shares for A$1.391 billion, or an average A$56.18 a share. Monday’s close sits 7.7% above that average. At A$60.51, the remaining A$1.109 billion would buy about 18.3 million shares. At the average price paid so far, it would buy about 19.7 million.

Buyback measureLatest figureInvestor read
Monday closeA$60.517.7% above average buyback price
Shares bought through June 2624.76 mlnAbout 4.0% of buyback filing class
Cash spent through June 26A$1.391 bln55.6% of A$2.5 bln program
Cash leftA$1.109 blnAbout 18.3 mln shares at Monday close
Lost buyback capacity vs past averageAbout 1.4 mln sharesAbout 0.23% of filing class

The price creep matters because the same cash cancels less stock. The remaining buyback is equal to about 3.0% of Aristocrat’s A$36.41 billion market value, but the share-count gain falls as the purchase price rises.

The daily filings show Aristocrat was close to the permitted top end last week. On June 24 and June 25, the highest price it paid matched the highest price allowed under ASX listing rule 7.33, at A$57.99 and A$58.86. On June 26, the highest price paid was A$59.31, below the A$59.62 allowed level.

June 26 was the heaviest of those three disclosed sessions. The company bought 193,344 shares that day, equal to 9.2% of the 2.09 million shares traded in the stock, based on Aristocrat’s own price table. By Monday, the stock had moved above the last disclosed buyback price range, with a high of A$60.62.

The operating base is still doing most of the work. In the half year to March, Aristocrat reported normalised NPATA of A$794.0 million, up 8.4% as reported and 16.3% in constant currency. Revenue was flat as reported at A$3.03 billion, but rose 6.4% in constant currency.

Chief Executive Trevor Croker said the half had “market share gains in key segments” and a “balanced approach to capital allocation”. He also said the company remained committed to the on-market buyback.

SegmentHY26 revenueHY26 segment profitProfit change, constant currency
GamingA$1.961 blnA$1.063 bln+10.3%
Product MadnessA$805.6 mlnA$373.3 mln+3.8%
InteractiveA$262.0 mlnA$95.2 mln-8.9%

Gaming supplied about 69% of segment profit in the half. Interactive supplied about 6%, but it carries the larger growth target: Aristocrat’s investor deck keeps a US$1 billion Interactive revenue target for fiscal 2029 and sets margin expansion as a goal.

The near-term cash return does not stop at the buyback. Aristocrat’s 50-cent interim dividend is due to be paid on July 1.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Ramsay Health Care's patient transfer trial draws criticism
    June 29, 2026, 4:23 PM EDT. Ramsay Health Care is running a trial to move privately insured patients from Queensland public hospital emergency departments to its private facilities. The Emergency Department Nurse Liaison program is supposed to ease public ED pressure. Critics say it could mean 'cherrypicking' low-cost, high-turnover cases for private hospitals. Health Consumers Queensland says some patients might feel pushed toward private care. Over 2,000 patients have been moved so far. Some want the program fully reviewed before it goes national. Ramsay posted a half-year net profit of AUD 160.7 million.